← Open Payments lookup

OGECHI AMACHUKWU: Open Payments

NPI 1679013429 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$7,205 in 65 payments from 18 companies in 2025. Trend: 2023 $105 · 2024 $1,973 · 2025 $7,205

Consulting: $5,625Food & beverage: $1,580
CompanyPaymentsAmount
Intrinsic Therapeutics14$5,976
ABBVIE INC.21$392
Merz Pharmaceuticals, LLC8$191
Globus Medical, Inc.1$150
SK Life Science, Inc.3$81
UCB, Inc.3$68
Averitas Pharma Inc.2$43
Eisai Inc.2$43
Lilly USA, LLC2$38
Ipsen Biopharmaceuticals, Inc1$34

Products named: BARRICAID ACD (ANNULAR CLOSURE DEVICE), BOTOX, Xeomin, EXCELSIUS GPS, QULIPTA, Rystiggo, QUTENZA, Leqembi.

Industry payments across TX — which companies pay providers there.